CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection (Q39006369)

8 September 2017

CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection (English)

1 reference

8 September 2017

Richardson Fleuridor

1

1 reference

8 September 2017

Brian Wilson

2

1 reference

8 September 2017

Runhua Hou

3

1 reference

8 September 2017

Alan Landay

4

1 reference

8 September 2017

Harold Kessler

5

1 reference

8 September 2017

Lena Al-Harthi

6

1 reference

8 September 2017

1 January 2003

1 reference

8 September 2017

1 reference

8 September 2017

108

1 reference

8 September 2017

1

1 reference

8 September 2017

3-9

1 reference

NKT cells: facts, functions and fallacies.

8 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Murine CD1d-restricted T cell recognition of cellular lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Evidence for two subgroups of CD4-CD8- NKT cells with distinct TCR alpha beta repertoires and differential distribution in lymphoid tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Immune suppression and skin cancer development: regulation by NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

NK cells and NKT cells in innate defense against viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Interleukin-18 (IL-18) and infectious diseases, with special emphasis on diseases induced by intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782862

T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782862

Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782862

Induction of IFN-gamma-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette Guérin.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782862

Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782862

Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782862

Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782862

Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1782862

Expression and selection of productively rearranged TCR beta VDJ genes are sequentially regulated by CD3 signaling in the development of NK1.1(+) alpha beta T cells

30 August 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

HIV phenotype correlates with the relative amounts of lymphocyte function-related molecule 1 (LFA-1) and major histocompatibility complex (MHC) class II in the virion envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2003.01560.X

NKT cells are phenotypically and functionally diverse

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12519296

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Role of innate immune cells in protection against Toxoplasma gondii at inflamed site

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12519296

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1046/J.1365-2567.2003.01560.X

1 reference

8 September 2017

0 references

1 reference